MorphoSys AktieWKN: 663200 / ISIN: DE0006632003

54,30EUR
+0,10EUR
+0,19%
24.03.2017
myfinanzen
teilen
KAUFEN
VERKAUFEN

MorphoSys News

23.03.17
DGAP-News: MorphoSys AG (EQS Group)
09.03.17
DGAP-News: MorphoSys AG (EQS Group)
06.03.17
DGAP-News: MorphoSys AG (EQS Group)
03.03.17
DGAP-News: MorphoSys AG (EQS Group)
02.03.17
DGAP-News: MorphoSys AG (EQS Group)
21.02.17
DGAP-News: MorphoSys AG (EQS Group)
15.02.17
DGAP-News: MorphoSys AG (EQS Group)
10.02.17
DGAP-News: MorphoSys AG (EQS Group)
01.02.17
DGAP-Vorabbekanntmachung: MorphoSys AG (EQS Group)
01.02.17
DGAP-Vorabbekanntmachung: MorphoSys AG (EQS Group)
12.01.17
MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes (Businesswire)
12.01.17
DGAP-News: MorphoSys AG (EQS Group)
05.01.17
Dr. Malte Peters to Become New Chief Development Officer of MorphoSys AG (Businesswire)
05.01.17
DGAP-News: MorphoSys AG (EQS Group)
03.01.17
MorphoSys to Present at Upcoming Investor Conferences (Businesswire)
03.01.17
DGAP-News: MorphoSys AG (EQS Group)
13.12.16
MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or Refractory CLL or SLL Previously Treated with a BTK Inhibitor (Hugin)
06.12.16
MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016 (Hugin)
06.12.16
MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 2016 Conference: (Hugin)
29.11.16
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution (Hugin)
28.11.16
MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application For Guselkumab in Europe (Hugin)
25.11.16
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution (Hugin)
22.11.16
Correction of a release from 21.11.2016, 18:05 CET - MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution (Hugin)
21.11.16
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution (Hugin)
21.11.16
MorphoSys AG: Notification of managers`transactions according to article 19 MAR (Hugin)
21.11.16
MorphoSys AG: Notification of managers`transactions according to article 19 MAR (Hugin)
17.11.16
MorphoSys Announces That Its Licensee Janssen Has Submitted Biologics License Application For Guselkumab (Hugin)
17.11.16
MorphoSys AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution (Hugin)
15.11.16
MorphoSys Raises EUR 115 million in Private Placement (Hugin)
15.11.16
Ad hoc: MorphoSys Raises EUR 115 million in Private Placement (Hugin)
15.11.16
MorphoSys to Raise Capital via a Private Placement of New Shares (Hugin)
15.11.16
Ad hoc: MorphoSys to Raise Capital via a Private Placement of New Shares (Hugin)
15.11.16
MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in Psoriatic Arthritis (Hugin)
14.11.16
MorphoSys to Present at Upcoming Investor Conferences (Hugin)
08.11.16
Anke Linnartz joins MorphoSys as Head of Corporate Communications and Investor Relations (Hugin)
07.11.16
MorphoSys AG Reports Results for the First Nine Months of 2016 (Hugin)
03.11.16
MorphoSys Announces Presentations of Clinical Data at Upcoming American Society of Hematology (ASH) Annual Meeting 2016 (Hugin)
02.11.16
MorphoSys and LEO Pharma Enter into Strategic Alliance to Develop Therapeutic Antibodies in Dermatology (Globe Newswire)
02.11.16
MorphoSys and LEO Pharma Enter into Strategic Alliance to Develop Therapeutic Antibodies in Dermatology (Hugin)
28.10.16
MorphoSys to Host Q3 2016 Conference Call on November 7, 2016 (Globe Newswire)
Seite: 123456789

MorphoSys News

MorphoSys News: auf dieser Seite finden Sie alle MorphoSys News und Nachrichten zur MorphoSys Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch MorphoSys News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um MorphoSys News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Daimler AG710000
Scout24 AGA12DM8
Allianz840400
BASFBASF11
Volkswagen AG Vz. (VW AG)766403
E.ON SEENAG99
Apple Inc.865985
Deutsche Telekom AG555750
BMW AG519000
Infineon Technologies AG623100
adidas AGA1EWWW
CommerzbankCBK100
Siemens AG723610
BayerBAY001